Pregabalin Toxicity: When a Common Pain Reliever Becomes a Threat
"Unmasking the danger of triphasic waves and encephalopathy linked to pregabalin toxicity, especially in those with kidney issues."
Triphasic waves, initially identified as indicators of liver dysfunction in 1955, are now known to appear in a variety of conditions, including metabolic imbalances, brain infections, and medication toxicities. These waves are frequently observed in patients with pre-existing white matter lesions or general cerebral atrophy, complicating the diagnostic process.
Several medications have been associated with triphasic waves, including common drugs like valproate, baclofen, and lithium. However, continuous triphasic waves caused by medications are rare, with very few instances linking these brainwave patterns to pregabalin toxicity.
This article highlights a case of a patient with underlying white matter lesions who developed triphasic waves and encephalopathy due to pregabalin toxicity, which was exacerbated by renal insufficiency. This case underscores the diagnostic challenges faced when patients with kidney or liver issues present with confusion and unusual brainwave patterns.
Decoding Triphasic Waves and Pregabalin Toxicity
A 41-year-old woman with a history of type I diabetes, post-pancreas transplant, and chronic kidney disease was admitted to the neurology service with acute encephalopathy. Her medication list included pregabalin for neuropathic pain, alongside other drugs for various conditions. Over the three days before admission, she became increasingly lethargic and showed signs of confusion.
- Elevated Creatinine: Serum creatinine was high, indicating kidney dysfunction.
- Brain Imaging: MRI showed white matter abnormalities.
- EEG Findings: Initial EEG showed abnormal brainwave patterns known as triphasic waves.
The Crucial Takeaway: Recognizing Medication-Induced Encephalopathy
This case highlights the importance of recognizing medication-induced encephalopathy, especially in patients with existing renal or hepatic issues. Discontinuing pregabalin led to significant improvements in the patient’s EEG and mental status, confirming pregabalin toxicity as the cause of her symptoms. Healthcare providers should be vigilant in monitoring patients on pregabalin, particularly those with impaired kidney function, to prevent such complications.